4 assets in Gaucher Disease Type I

Therapeutic assets addressing Gaucher Disease Type I, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
.Alpha.-D-Glucosyl-N-Acylsphingosine Glucohydrolase Gaucher Disease Type I	Sanofi	P4	A (83)
flt201 Gaucher Disease Type I	Spur Therapeutics	P3	B (60)
Venglustat Gaucher Disease Type I	Genzyme, a Sanofi Company	P2	CCC (53)
Ly-M001 Gaucher Disease Type I	Lingyi Biotech Co., Ltd.	P1/2	CCC (48)